Setback for state’s AIDS drugs plan as investor pulls out
Government’s plans for a state-owned pharmaceutical company that will manufacture key ingredients for AIDS drugs delayed as Swiss investor pulls outNew Discovery body to research lifestyle diseases
Discovery launches institute to conduct scientific research into lifestyle-related disease
Mediclinic exhorts market probe to scrutinise everyone
Mediclinic and rivals call for the Competition Commission’s market inquiry to spare no sector from scrutiny
Actis could be a suitor for Adcock Ingram
London-based private equity firm Actis has emerged as a possible bidder for South Africa’s second-biggest drug maker, according to a source close to the deal
Pharmacies get tough on codeine abuse
Retail pharmacy sector poised to exercise stricter control over sales of medicines containing codeine
New pharmaceutical body to tackle drug registration delay
First order of business for Innovative Pharmaceutical Association of SA will be dealing with delays in registering new products
Netcare CEO says Competition Commission must also probe pharmaceuticals
CEO Richard Friedland says he is disappointed that Competition Commission’s planned inquiry into private healthcare sector will exclude pharmaceutical sector
Takeover expected to make Cipla Medpro’s pricing more competitive
Move by India’s Cipla offers savings, and may put pressure on competitors in South Africa
Netcare’s earnings rise, helped in part by weaker rand
Hospital group says half-year earnings driven by strong performance at local operations, while UK profit dented by higher proportion of National Health Service patients
Motsoaledi urges medical schemes to pay for cancer vaccines
Minister says the government will begin providing cervical cancer vaccines to girls from poor families attending state schools from February, and calls on funders to help
Private health costs inquiry welcomed
Life Healthcare calls for ‘holistic’ Competition Commission probe
- Adcock stock on track to gain from bidding war
- French drug firm touted as Adcock bidder
- Life Healthcare’s profit growth slows
- Bidvest still wants Adcock, says Joffe
- Discovery medical scheme members to get answers from administrator in June
- Ruling could help Adcock get drugs back on market
- Competition Commission to probe healthcare costs, says Patel
- Bidding war looms after surprise Adcock offer
- Selfmed duo face inquiry over ‘failed governance’
- Nehawu vows to maintain Netcare strike until demands met
- Private hospitals drive medical imaging investment
- Shareholders want sight of Cipla Medpro supply deal
- Litha stock tanks despite profit turnaround
- Bidvest may have rival bidder for Adcock Ingram
- Bidvest may see Adcock as defensive play
- Cipla Medpro South Africa sees earnings fall 32%
- Bidvest sees Adcock Ingram’s similarities
- Aspen makes offer for Pfizer baby formula units
- Johnson & Johnson may cause wrinkles in the Botox market
- Restatement to hit Cipla Medpro earnings
- Bidvest offer for Adcock a ‘cheeky move’
- Bidvest defends offer but Adcock says it has lapsed
- Medical device industry says revised BEE codes ‘unfair’
- Competition watchdog to get ‘invasive’ new powers
- Discovery Health chief executive Adrian Gore on profits vs people
- Not so sweet surprise in Cipla's India deal
- Virgin Active not resting on its laurels in South Africa
- Cipla India ups offer for South African firm
- Litha’s earnings plunge as rand weakens
- Government’s ARV programme ‘increasing life expectancy’
- Pharmaceutical firms eye Africa
- Hospices in South Africa cut capacity as US reduces funding
- Cipla Medpro denies acquisition talks put on hold
- Aspen targets Netherlands plant
- Discovery backs global Charter for Healthy Living
- Medical aid chairman loses bid to halt probe
- Grant spat puts future of McCord in doubt
- Take a digipill and call me tomorrow
- Cadres make way for new hospital CEOs
- Payments to former Cipla Medpro CEO ‘unlawful’
- Cipla calls former CEO’s allegations ‘provocative and misleading’
- Ousted CEO sues Cipla in multimillion-rand payout wrangle
- Aspen profit up on sales, costs savings
- State to introduce three-in-one AIDS pill
| All Share | 40998.58 | 0.00% | same |
| Top 40 | 36444.22 | 0.00% | same |
| Financial 15 | 11703.85 | 0.00% | same |
| Industrial 25 | 46637.62 | 0.00% | same |
| Resource 10 | 46049.93 | 0.00% | same |
Data supplied by I-Net Bridge
| FTSE 100 | 6654.34 | 0.00% | same |
| Dow Jones | 15303.10 | 0.00% | same |
| All Share | 40998.58 | 0.00% | same |
| ASX | 4964.30 | 0.00% | same |
| S&P 500 | 1649.600 | 0.00% | same |
Data supplied by I-Net Bridge
| USD/ZAR | 9.5763 | 0.07% | up |
| GBP/ZAR | 14.4987 | 0.23% | up |
| EUR/ZAR | 12.3835 | 0.04% | up |
| JPY/ZAR | 0.0947 | 0.12% | up |
| AUD/ZAR | 9.2810 | 0.40% | up |
Data supplied by I-Net Bridge
| Gold | 1386.6000 | 0.03% | up |
| Platinum | 1452.5000 | 0.31% | up |
| Silver | 22.4000 | 0.16% | up |
| Palladium | 727.0000 | 0.55% | up |
| Brent Crude Oil | 102.640 | 0.00% | same |
Data supplied by I-Net Bridge
Share search
Top 100 Companies 2012
Click here to view or download Business Times's full Top 100 Companies 2012 report (PDF, 7MB)
Register/Login
Close XMy News
You can only set up or view personalised news headlines when you are logged in as a registered user. Thereafter you can choose the sectors of industry in which you are interested, and the latest articles from those sectors will display in this area of your console.
Login or Register.Top Stories
My Watchlist
You can only set up or view your share watchlist when you are logged in as a registered user. Thereafter you can select a list of companies and enter your share details to monitor their performance.
Login or Register.My Clippings
You can only clip articles when you are logged in as a registered user. Thereafter you can click on the "Read later" icon at the top of an article to save it to this area of your console, where you can return to read it at any time.
Login or Register.Change: 0.00%
Change: 0.00%
Change: 0.00%
Change: 0.00%
Change: 0.00%
Data supplied by I-Net Bridge
Change: 0.00%
Change: 0.00%
Change: 0.00%
Change: 0.00%
Change: 0.00%
Data supplied by I-Net Bridge
Change: 0.07%
Change: 0.23%
Change: 0.04%
Change: 0.12%
Change: 0.40%
Data supplied by I-Net Bridge
Change: 0.03%
Change: 0.31%
Change: 0.16%
Change: 0.55%
Change: 0.00%
Data supplied by I-Net Bridge